CellPro regulatory update

CPRO's Ceprate SC Stem Cell Concentration System will be reviewed by the FDA's Biological Response Modifiers Advisory Committee in late February. Ceprate is used to separate stem cells from other bone marrow or peripheral blood cells in autologous bone marrow transplantation. ...